Markets

Fresenius Medical Shows Market Leadership With Jump To 82 RS Rating

Shutterstock photo

The Relative Strength ( RS ) Rating for Fresenius Medical ( FMS ) jumped into a new percentile Tuesday, with a rise from 79 to 82.

[ibd-display-video id=2385970 width=50 float=left autostart=true] This proprietary rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks matches up against the rest of the market.

Decades of market research shows that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Fresenius Medical has climbed more than 5% past a 50.23 entry in a first-stage flat base , meaning it's now out of a proper buy range. Look for the stock to offer a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week moving average.

While sales growth fell last quarter from 14% to 8%, earnings-per-share grew 5%, up from 4% in the prior report.

Fresenius Medical earns the No. 1 rank among its peers in the Medical-Outpatient/Home Care industry group. US Physical Therapy ( USPH ) and HealthSouth ( EHC ) are also among the group's highest-rated stocks.

RELATED:

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RS EHC FMS USPH

Other Topics

Stocks

Latest Markets Videos